Klin Farmakol Farm. 2011;25(3):142-143

Probiotics in treating liver disease

Jan Lata1, Jana Juránková2
1 Interní klinika LF OU a FN Ostrava
2 Oddělení klinické mikrobiologie FN Brno

The World Health Organization defines probiotics as "live microorganisms which when administered in adequate amounts confer a health

benefit on the host." The paper provides a basic review of indications of probiotics in hepatology – treatment of liver encephalopathy,

non-alcoholic steatohepatitis, prevention of complications of liver cirrhosis and infection after liver transplantation.

Keywords: probiotics, liver cirrhosis, liver encephalopathy, non-alcoholic steatohepatitis, liver transplantation

Published: December 1, 2011  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Lata J, Juránková J. Probiotics in treating liver disease. Klin Farmakol Farm. 2011;25(3):142-143.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Besselink MGH, Santyoort HC, Buskens E, et al. Probiotic prophylaxis in predicted severe acute pancreatitis: a randomized, double-blind, placebo-controlled trial Lancet 2008; 372: 112-113. Go to original source... Go to PubMed...
    2. Gratz SW, Mykkanen H, El-Nezami HS. Probiotics and gut health: A special focus on liver diseases. J Gastroenterol 2010; 16(4): 403-410. Go to original source... Go to PubMed...
    3. Lata J, Juránková J. Střevní mikroflóra, slizniční bariéra a probiotika u některých interních chorob. Interní Med 2011; 13(2): 63-69.
    4. Havenaar R, Ten Brink B, Huis in't Veld JHJ. Selection of strains for probiotic use. Probiotics: the Scientific Basis) London: Chapman and Hall 1992: p209-224. Go to original source...
    5. Ankur G, Radha KD, Savita K, et al. Role of small intestinal bacterial overgrowth and delayed gastrointestinal transit time in cirrhotic patients with minimal hepatic encephalopathy J Hepatol 2010; 53/5: 849-855. Go to original source... Go to PubMed...
    6. Foster KJ, Lin S, Turck CJ. Current and emerging strategies for treating hepatic encephalopathy. Crit Care Nurs Clin North Am 2010; 22(3): 341-350 PMID: 20691385. Go to original source... Go to PubMed...
    7. Macbeth WA, Kass EH, Mcdermott WV Jr. Treatment of hepatic encephalopathy by alteration of intestinal flora with lactobacillus acidophilus. Lancet 1965; 191: 399-403. Go to original source... Go to PubMed...
    8. Boča M, Vyskočil M, Mikulecký M. Komplexní léčba chronické jaterní encefalopatie probiotiky. Čas Lék Čes 2004; 143: 324-328.
    9. Malaguarnera M, Gargante MP, Malaguarnera G, et al. Bifidobacterium combined with fructo-oligosaccharide versus lactulose in the treatment of patients with hepatic encephalopathy. Eur J Gastroenterol Hepatol 2010; 22(2): 199-206. Go to original source... Go to PubMed...
    10. Bajaj JS, Saeian K, Christensen KM, et al. Probiotic yogurt for the treatment of minimal hepatic encephalopathy. Am. J Gastroenterol. 2008; 103(7): 1707-1715. Go to original source... Go to PubMed...
    11. Jia L, Zhang MH. Comparison of probiotics and lactulose in the treatment of minimal hepatic encephalopathy in rats. J Gastroenterol 2005; 11(6): 908-911. Go to original source... Go to PubMed...
    12. Lata J, Novotny I, Pribramska V, et al. The effect of probiotics on gut flora, level of endotoxin and Child-Pugh score in cirrhotic patients: results of a double-blind randomized study. Eur J Gastroenterol Hepatol. 2007; 19(12): 1111-1113. Go to original source... Go to PubMed...
    13. Forsyth CB, Farhadi A, Jakate SM, et al. Lactobacillus GG treatment ameliorates alcohol-induced intestinal oxidative stress, gut leakiness, and liver injury in a rat model of alcoholic steatohepatitis. Alcohol 2009; 43(2): 163-172. Go to original source... Go to PubMed...
    14. Ludwig TR, Viggiano DB, McGill, et al. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hithrerto unnamed disease. Mayo Clin Proc 55 1980; 55: 434-438.
    15. Li Z, Yang S, Lin H, et al. Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease. Hepatology 2003; 37: 343-350. Go to original source... Go to PubMed...
    16. Lirussi F, Mastropasqua E, Orando S, Orlando R. Probiotics for non-alcoholic fatty liver disease and/or steatohepatitis. Cochrane Database of Systematic Reviews 2007, Issue 1. Art. No.: CD005165. Go to original source...
    17. Reddy BS, Macfie J, Gatt M, et al. Randomized clinical trial of effect of synbiotics, neomycin and mechanical bowel preparation on intestinal barrier function in patients undergoing colectomy. Br J Surg 2007; 94: 546-554. Go to original source... Go to PubMed...
    18. Rayer N, Seehofer D, Theruvath T, et al. Supply of pre- and probiotics reduces bacterial infection rates after liver transplantation - a randomized double-blinde trial. Am J Transplant 2005; 5: 125-130. Go to original source... Go to PubMed...
    19. Juránková J, Příbramská V, Lata J, et al. Průkaz translokace bakterií ze střeva po transplantaci jater - první výsledky. Čes a Slov Gastroent a Hepatol 2008; 5: 253-258.

    Return to the content


    Clinical Pharmacology and Pharmacy

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.